• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PICCOLO; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PICCOLO; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number OCCLUDER
Medical Device Problem Codes Migration or Expulsion of Device (1395); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/15/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2023, a 5-4mm amplatzer piccolor occluder was implanted in a patient to treat patent ductus arteriosus (pda).The dimensions of the defect measured 2.7mm for pulmonary artery diameter, 3.5mm aortic diameter, and 9mm for ductal length.The patient was extubated and transferred to pediatric intensive care unit (picu).It was reported that a murmur was detected in the patient upon arrival and the device was found to have embolized into the left lower anterior basal pulmonary artery via echocardiogram.A decision was made to reintubate the patient and an attempt was made to retrieve the device using a snaring method but was unsuccessful.The patient was scheduled for surgical removal of the device which occurred on (b)(6) 2023.It was reported the physician did not believe there was partial or complete blockage of blood flow.The patient status was reported stable.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of embolization of the 5/4mm piccolo occluder was reported.A review of the ductal measurements as reported from the field was performed.Per the sizing table in the instructions for use, sizing chart t2, the recommended size devices for patients >2kg have a maximum duct length of 6mm, and therefore the 9mm patent ductus arteriosus length of the reported event falls outside recommended sizing.A returned device assessment could not be performed as the device and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could potentially be related to the user not following the recommended sizing chart provided in the ifu.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PICCOLO
Common Device Name
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16704700
Report Number2135147-2023-01540
Device Sequence Number3676886
Product Code MAE
UDI-Device Identifier05415067031044
UDI-Public05415067031044
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P020024
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberOCCLUDER
Device Catalogue Number9-PDAP-05-04-L
Device Lot Number8538533
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/15/2023
Supplement Date Received by Manufacturer06/05/2023
Initial Report FDA Received Date04/07/2023
Supplement Report FDA Received Date06/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/24/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age8 MO
Patient SexMale
Patient Weight5 KG
-
-